Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/1998
07/22/1998EP0853488A2 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes
07/22/1998EP0853487A1 Neutralizing monoclonal antibodies to respiratory syncytial virus
07/22/1998EP0853485A1 Therapeutic administration of hemoglobin in cardiac arrest
07/22/1998EP0853484A1 Novel mu opioid receptor ligands: agonists and antagonists
07/22/1998EP0853483A1 Novel peptides
07/22/1998EP0853475A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products
07/22/1998EP0853450A1 Treatment of vascular injury
07/22/1998EP0789577A4 Synthesis of n-substituted oligomers
07/22/1998EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
07/22/1998EP0690991B1 Novel anticoagulant cofactor activity
07/22/1998EP0643767B1 Osteogenic peptides
07/22/1998EP0610502B1 Emulsion containing parathyroid hormone for pernasal administration
07/22/1998EP0517859B1 Oligonucleotide therapies for modulating the effects of herpesviruses
07/22/1998EP0444157B1 Collagen-polymer conjugates
07/22/1998EP0415999B1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits
07/22/1998CN1188512A Efflux pump inhibitors
07/22/1998CN1188509A Proteinase K resistant surface protein of neisseria meningitidis
07/22/1998CN1188508A Genetic sequences and proteins related to alzheimer's disease, and uses therefor
07/22/1998CN1188485A Glucagon-like peptide-2 and its therapeutic use
07/22/1998CN1188484A Compounds with growth hormone releasing properties
07/22/1998CN1188483A Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases
07/22/1998CN1188416A Multimeric recombinant urease vaccine
07/22/1998CN1188415A Method for control of antibiotic-resistant gram positive bacteria and treatment of infection
07/22/1998CN1188414A Novel formulation for peptide release
07/22/1998CN1188413A Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders
07/22/1998CN1188408A Novel 'burst-free' sustained release poly-(lactide/glycolide) mi crospheres
07/22/1998CN1188151A Method for preparing recombination human basic fibroblastic growth factor and its use
07/22/1998CN1188149A Multifunctional ligan system for cell-specific transfer of nucleic acid
07/22/1998CN1039231C 因子vii的纯化 The purified factor vii
07/22/1998CA2200541A1 Lhrh-antagonists in the treatment of fertility disorders
07/21/1998US5783701 Anti-hiv viricides
07/21/1998US5783693 Sulfation lactose with sulfur trioxide
07/21/1998US5783683 Antisense oligonucleotides which reduce expression of the FGFRI gene
07/21/1998US5783681 Androgen regulation with DNA sequences of rat probasin gene
07/21/1998US5783671 Method and composition for preparation of factor VIIIC
07/21/1998US5783670 Monoclonal antibodies specific for HIV and the hybridomas for production thereof
07/21/1998US5783664 Cytokine suppressive anit-inflammatory drug binding proteins
07/21/1998US5783662 Polyphosphoinsitide binding peptides for intracellular drug delivery
07/21/1998US5783661 Polypeptide encoded by a nucleic acid capable of hybridizing under stringent conditions to a cyclin e nucleotide sequence
07/21/1998US5783598 Antiretroviral naphthoquinone compounds compositions and uses thereof
07/21/1998US5783568 Methods for treating cancer and other cell proliferative diseases
07/21/1998US5783563 Method for treatment or prophylaxis of venous thrombosis
07/21/1998US5783562 Luteinizing hormone releasing hormone analogs
07/21/1998US5783561 Anti-gram-positive bacterial methods and materials
07/21/1998US5783560 Use of human growth hormone for preoperative administration
07/21/1998US5783559 Solution containing IGF-1
07/21/1998US5783558 Treatment of bone disorders; calcium regulation
07/21/1998US5783557 THF-γ2 analogs and pharmaceutical compositions comprising them
07/21/1998US5783556 Formulated insulin-containing composition
07/21/1998US5783555 Storge stability; trypsin inhibitor; stabilizer is selected form basic or acidic amino acids and salts, gelatin, albumin, disaccharides and sugar alcohol
07/21/1998US5783434 Cathepsin and methods and compositions for inhibition thereof
07/21/1998US5783433 Ion exchanging
07/21/1998US5783432 Polypeptides and dna codes; treatment of bacterial infections
07/21/1998US5783425 Amino and peptido modified enzymatic nucleic acid
07/21/1998US5783422 DNA fragment coding for squamous cell carcinoma-associated antigen
07/21/1998US5783421 DNA encoding novel polypeptide having Factor Xa inhibitory activity
07/21/1998US5783417 Human-derived tumor cell growth inhibitors
07/21/1998US5783416 Treatment of gastrointestinal disorders
07/21/1998US5783415 Method of producing an IL-8 receptor polypeptide
07/21/1998US5783405 Rapid screening method for effectors of signal transduction
07/21/1998US5783403 Cancer diagnosis, therapy
07/21/1998US5783216 Adjustment, removal or masking antigen
07/21/1998US5783197 Veterinary medicine
07/21/1998US5783193 Therapeutic antigens microencapsulated in water based protective enteric coating which is completely free of organic solvents
07/21/1998US5783188 Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences
07/21/1998US5783187 Treatment of cell proliferative disorders using antibodies which bind connective tissue growth factor
07/21/1998US5783186 Antibody-induced apoptosis
07/21/1998US5783185 Monoclonal antibodies to transforming growth factor-beta and methods of use
07/21/1998US5783184 Administering monoclonal antibodies
07/21/1998US5783181 Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins
07/21/1998US5783179 Anticarcinogenic dodecapeptide having known amino acid sequence and protected or unprotected amino acid end groups
07/21/1998US5783170 Peptide-metal chelate conjugates
07/21/1998CA2220850A1 Novel aroe
07/21/1998CA2067133C Liposome microreservoir composition and method
07/21/1998CA2011874C Sdk peptides, a preparation process of the same and therapeutic compositions containing them
07/21/1998CA1339962C Introduction and expression of foreign genetic material in epithelial cells
07/17/1998CA2227046A1 Peptides for use in wound treatment
07/16/1998WO1998030709A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy
07/16/1998WO1998030707A2 Eukaryotic gene expression cassette and uses thereof
07/16/1998WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
07/16/1998WO1998030704A1 Csk homologous kinase (chk) for detecting and treating breast cancer
07/16/1998WO1998030696A2 Secreted proteins and polynucleotides encoding them
07/16/1998WO1998030693A2 Tumor necrosis factor receptor 5
07/16/1998WO1998030692A2 Human endosulfine gene
07/16/1998WO1998030691A1 Human chloride channel protein (hccp)
07/16/1998WO1998030687A2 Protein containing an srcr domain
07/16/1998WO1998030592A1 Novel epithelial tissue targeting agent
07/16/1998WO1998030590A2 Analogs of parathyroid hormone
07/16/1998WO1998030589A2 Secreted proteins and polynucleotides encoding them
07/16/1998WO1998030588A1 Specific pancreatic lipase inhibitors and their applications
07/16/1998WO1998030585A2 Use of pea3 in tumor suppression
07/16/1998WO1998030584A2 Secreted proteins and polynucleotides encoding them
07/16/1998WO1998030583A1 Complexes and combinations of fetuin with therapeutic agents
07/16/1998WO1998030582A2 Secreted proteins and polynucleotides encoding them
07/16/1998WO1998030581A1 Myelopeptides and their therapeutic use
07/16/1998WO1998030577A1 RECOMBINANT HUMAN IgA-J. CHAIN DIMER
07/16/1998WO1998030576A1 Novel hedgehog-derived polypeptides
07/16/1998WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION
07/16/1998WO1998030255A2 Localized intravascular delivery of antioxidant substances for inhibition of restenosis in recanalized blood vessels
07/16/1998WO1998030247A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents